
Please try another search
By Dhirendra Tripathi
Investing – Moderna (NASDAQ:MRNA) shares rose more than 2% Monday as the company sought to strengthen its global presence as a key supplier of Covid-19 vaccines by expanding its agreement with Aldevron, its existing supplier of plasmid DNA.
Moderna and Pfizer (NYSE:PFE)-BioNTech's (NASDAQ:BNTX) Covid-19 vaccines, based on mRNA technology, have been found to be most efficient in developing antibodies against the coronavirus.
Aldevron’s production of DNA is already taking place in its 70,000 square foot facility in Fargo, North Dakota. Buildout and validation of an additional 189,000 square foot expansion has been completed, enabling additional manufacturing capacity.
The company, founded in 1998, will supply plasmid DNA to serve as the genetic template for generating the Covid-19 mRNA vaccine and other investigational programs in Moderna’s pipeline.
Aldevron provides critical nucleic acids and proteins used to make gene and cell therapies. It is a leading provider of high-quality plasmid DNA, mRNA and recombinant proteins necessary for vaccines, gene and cell therapy, gene editing and diagnostic applications.
Moderna has forecast supplying 800 million to 1 billion doses of its Covid-19 vaccine in 2021 with another 2 billion doses to be supplied in 2021, the production coming from its own and partners’ facilities.
(Corrects headline and first paragraph to show that payment is a settlement between the banks and Brazil's watchdog, it is not a fine; adds Citibank statement in last paragraph...
By Daniel Wiessner (Reuters) - A federal judge in California on Monday ordered a new trial on the damages Tesla (NASDAQ:TSLA) Inc owes to a Black former factory worker who accused...
By Stephen Culp NEW YORK (Reuters) - Wall Street lost ground on Monday, with few catalysts to inspire much conviction as investors approach the midway point of a year in which...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.